{
  "id": "SCR-LIP-000496",
  "statement": "Among 440 lower-extremity lymphedema patients, 52 had lipedema with secondary lymphedema (lipolymphedema), of whom 88.5% showed permanent foot/dorsum edema consistent with ISL stage II-III secondary lymphedema and 38.5% had a history of cellulitis.",
  "statement_pt": "Entre 440 pacientes com linfedema de membros inferiores, 52 tinham lipedema com linfedema secundário (lipolinfedema), dos quais 88,5% apresentaram edema permanente de pé/dorso do pé consistente com linfedema secundário estágio II-III da ISL e 38,5% tinham história de celulite.",
  "claim_type": "clinical_association",
  "context": {
    "population": "440 patients with lower-extremity lymphedema, including 52 with lipolymphedema",
    "condition": "lipedema",
    "exposure": "lipedema (with secondary lymphedema / lipolymphedema)",
    "comparator": "other lymphedema etiologies (PhLE, CRLE, PLE)",
    "outcome": "ISL lymphedema staging, foot edema, cellulitis history",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "title": "The clinical characteristics of lower extremity lymphedema in 440 patients",
      "ref": "DOI:10.1016/j.jvsv.2019.11.014",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2020,
      "amato_authored": false,
      "quote": "88,5% dos pacientes com lipedema apresentaram edema permanente de pé/dorso do pé consistente com linfedema secundário estágio II ou III",
      "extraction_confidence": "high",
      "note": "Retrospective chart review documents that lipedema patients progressed to secondary lymphedema (stage II-III) with permanent foot edema and cellulitis, supporting progression to lymphedema; functional disability is not directly measured but",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. The article explicitly states 52/440 patients had lipolymphedema (11.8%), 88.5% showed permanent foot/dorsum edema consistent with ISL stage II or III secondary lymphedema, and 38.5% had a ",
        "date": "2026-11-17"
      }
    }
  ],
  "relations": [],
  "gaps": "Auto-ingested single source; not yet human-reviewed.",
  "primary_amato_source": null,
  "curators": [],
  "provenance": {
    "auto": true,
    "engine": "anthropic/claude-opus-4.8",
    "question": "SQ-LIP-000017",
    "source": "library",
    "ingested": "2026-11-17"
  },
  "created": "2026-11-17",
  "updated": "2026-11-17",
  "history": [
    {
      "date": "2026-11-17",
      "event": "created",
      "detail": "auto-ingested for SQ-LIP-000017"
    },
    {
      "date": "2026-11-20",
      "event": "consolidated",
      "detail": "SQ-LIP-000017: evidence moved to SCR-LIP-000672"
    }
  ],
  "license": "CC-BY-4.0",
  "superseded_by": [
    "SCR-LIP-000672"
  ],
  "status": "superseded",
  "answers_questions": [],
  "url": "https://scientificclaims.org/c/SCR-LIP-000496.html"
}